VIR BIOTECHNOLOGY, INC.

SAN FRANCISCO, CALIFORNIA 94158

$120.87M
Total Contract Value
6 awards
First Award
Sep 28, 2022
Last Award
Aug 5, 2025
Business Size
small
CAGE Code
80UV6

Top Industries (NAICS)

NAICS CodeObligationsAwards
541714$65.87M5

Contract Awards

4 awards found

75A50122C00081
Department of Health and Human Services
$-8,358,581.51
Aug 5, 2025

VIR BIOTECHNOLOGY - OTA FOR PRE-EXPOSURE PROPHYLACTIC MONOCLONAL ANTIBODIES FOR THE PREVENTION OF INFLUENZA ILLNESS AND MEDICAL COUNTERMEASURES FOR OTHER EMERGING PATHOGENS OF PANDEMIC POTENTIAL

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025
75A50122C00081
Department of Health and Human Services
$-42,074,015.5
Sep 9, 2024

VIR BIOTECHNOLOGY - OTA FOR PRE-EXPOSURE PROPHYLACTIC MONOCLONAL ANTIBODIES FOR THE PREVENTION OF INFLUENZA ILLNESS AND MEDICAL COUNTERMEASURES FOR OTHER EMERGING PATHOGENS OF PANDEMIC POTENTIAL

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75A50122C00081
Department of Health and Human Services
$61.30M
Sep 28, 2023

VIR BIOTECHNOLOGY - OTA FOR PRE-EXPOSURE PROPHYLACTIC MONOCLONAL ANTIBODIES FOR THE PREVENTION OF INFLUENZA ILLNESS AND MEDICAL COUNTERMEASURES FOR OTHER EMERGING PATHOGENS OF PANDEMIC POTENTIAL

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
75A50122C00081
Department of Health and Human Services
$55.00M
Sep 28, 2022

VIR BIOTECHNOLOGY - OTA FOR PRE-EXPOSURE PROPHYLACTIC MONOCLONAL ANTIBODIES FOR THE PREVENTION OF INFLUENZA ILLNESS AND MEDICAL COUNTERMEASURES FOR OTHER EMERGING PATHOGENS OF PANDEMIC POTENTIAL

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2022

Business Details

UEI
VAGNEFK9N5X7
CAGE Code
80UV6
Address
499 ILLINOIS STREET
SUITE 500
SAN FRANCISCO, CA 94158
Congressional District
CA-11

Parent Company

VIR BIOTECHNOLOGY, INC.

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov